X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.01
Delayed Data
As of 2:13pm ET
 -0.043 / -2.09%
Today’s Change
1.55
Today|||52-Week Range
5.00
+1.52%
Year-to-Date
Institutional investors purchased a net $1.3 million shares of XTLB during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 10.56% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Other institutional10.33%
Mutual fund holders0.23%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

3/31/2015SABBY CAPITAL LLC  Bought 1.3 Million shares of X T L Biopharmaceuticals ...
3/31/2015UBS SECURITIES LLC  Bought 1.5 Thousand shares of X T L Biopharmaceuticals ...
3/31/2015TOWER RESEARCH CAPITAL LLC  Sold 1.0 Thousand shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Sabby Capital LLC9.59%1,311,4532,872,082+1,311,453--
Invesco Asset Management Ltd.0.95%129,811284,28600.00%
UBS Securities LLC0.02%3,0246,623+1,450+92.12%
Tower Research Capital LLC0.00%00-1,026-100.00%
Morgan Stanley & Co. LLC0.00%4900.00%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Keystone Investment Trust Plc0.19%25,84056,590+92+0.36%
Invesco Perpetual UK 2 Invt. Seri...0.04%5,95813,04800.00%

To view my watchlist

Not a member yet?

Sign up now for a free account